Structure and Catalytic Mechanism of 3-Ketosteroid Dehydrogenases  by Dijkstra, Bauke W. et al.
 Procedia Chemistry  18 ( 2016 )  3 – 11 
1876-6196 © 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Peer-review under responsibility of the organizing committee of the Molecular and Cellular Life Sciences: Infectious Diseases, Biochemistry and 
Structural Biology 2015 (MCLS 2015)
doi: 10.1016/j.proche.2016.01.006 
Available online at www.sciencedirect.com
ScienceDirect
Molecular and Cellular Life Sciences: Infectious Diseases, Biochemistry and Structural Biology 
2015 Conference, MCLS 2015 
Structure and Catalytic Mechanism of 3-Ketosteroid 
Dehydrogenases 
Bauke W. Dijkstraa*, Niels van Oosterwijka, Ali Rohmana,b 
aLaboratory of Biophysical Chemistry, University of Groningen, Nijenborgh 7, 9747 AG Groningen, the Netherlands 
bDepartment of Chemistry, Faculty of Sciences and Technology, Universitas Airlangga, Kampus C Unair, Jl. Mulyorejo, Surabaya 60115, 
Indonesia  
Abstract 
3-Ketosteroid dehydrogenases (KSTDs) are FAD-dependent enzymes that introduce a double bond in the A ring of 3-ketosteroid 
substrates to initiate degradation of the steroid nucleus. '1-KSTD desaturates the C1-C2 bond of the steroid, while '4-KSTD 
targets the C4-C5 bond. Crystal structures with bound products showed that '1- and '4-KSTD use different amino acid residues to 
catalyze an otherwise mechanistically very similar reaction ('1-KSTD: Tyr318, Tyr119, and Tyr487; '4-KSTD: Ser468, Tyr319, 
and Tyr466). However, the substrates are rotated by ~40° about an axis perpendicular to their plane to bring the target bond (C1-
C2 or C4-C5) in the right position. 
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Nomenclature 
KSTD  3-ketosteroid dehydrogenase 
'1-KSTD  3-ketosteroid-ǻ1-dehydrogenase 1 from Rhodococcus erythropolis SQ1 
'4-KSTD  3-ketosteroid-ǻ4-(5Į)-dehydrogenase from Rhodococcus jostii RHA1 
4-AD  4-androstene-3,17-dione 
ADD  1,4-androstadiene-3,17-dione 
RMSD  root-mean-square difference 
1. Introduction 
Phytosterols are a large group of steroidal triterpenes that widely occur in nature. They are structurally and 
physiologically similar to cholesterol and are essential to maintaining normal function in plant cell membranes. Many 
enzymes occur in nature that act upon such phytosterols, and a huge interest exists to use such enzymes to convert 
phytosterols into high-value-added products1. 
An important group of enzymes involved in the conversion of the steroid core are the 3-ketosteroid 
dehydrogenases (KSTDs), which are FAD-containing enzymes that introduce a double bond in the A-ring of 3-
ketosteroids. 3-Ketosteroid-'1-dehydrogenases ('1-KSTDs) desaturate the bond between the C1 and C2 atoms of the 
A ring (see Fig. 1 for reaction and nomenclature), while the 3-ketosteroid-'4-dehydrogenases ('4-KSTDs) target the 
bond between the C4 and C5 atoms. In bacteria, '1-KSTD and '4-KSTD are responsible for the initiation of 
degradation of the steroid core. Together, they introduce two double bonds in the A ring of their ketosteroid 
substrates. Subsequently, a 3-ketosteroid-9D-hydroxylase introduces a hydroxyl group at the C9 position in the B 
ring, which leads to the spontaneous, non-enzymatic opening of the 3-ketosteroid B ring via a reverse-aldol reaction 
and aromatization of the A ring (Fig. 1). Some of the products of the bacterial 3-ketosteroid dehydrogenases belong 
to the most marketed intermediates for the production of pharmaceutical steroids, such as 5Į-androstane-3,17-dione 
(1-(5Į)-AD) and 1,4-androstadiene-3,17-dione (ADD)2. 
 
 
 
 
Fig. 1. Conversion of the key metabolic compound 5D-AD into HSA (3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione), by '1-KSTD 
(reactions (a)), '4-KSTD (reactions (b)), and 3-ketosteroid 9D-hydroxylase (reactions (c)) into the unstable intermediate 9-OHADD (9D-hydroxy-
1,4-androstadiene-3,17-dione), which undergoes spontaneous, non-enzymatic B-ring cleavage and A-ring aromatization to form HSA. 
 
Here we discuss the crystal structures of the '1-KSTD from Rhodococcus erythropolis SQ1 and the '4-KSTD 
from Rhodococcus jostii RHA1, and deduce their catalytic mechanisms from crystal structures with bound product. 
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2. Methods 
The cloning, overexpression, purification, crystallization and preliminary X-ray analysis of the 3-ketosteroid-ǻ4-
(5Į)-dehydrogenase from Rhodococcus jostii RHA1 ('4-KSTD) has been described in detail by van Oosterwijk et 
al.3. Crystals were obtained from a condition consisting of 200 mM ammonium acetate, 100 mM sodium citrate, pH 
5.6, and 30% (w/v) PEG-4000 at 293 K. They grew in about 1-2 weeks, and diffracted to a resolution of 1.6 Å. They 
belonged to space group C2221 with unit cell parameters a = 99.2, b = 114.3, c = 110.2 Å, and had one 52 kDa 
protein molecule per asymmetric unit. The structure elucidation of the enzyme, and a description of its three-
dimensional structure and the enzyme’s putative catalytic mechanism has been published4. 
Similarly, the overexpression, purification, crystallization, and preliminary X-ray crystallographic analysis of 3-
ketosteroid-ǻ1-dehydrogenase from Rhodococcus erythropolis SQ1 ('1-KSTD) was published by Rohman et al.5. '1-
KSTD crystals were routinely obtained in 5-7 days at 293 K using condition No. 30 of Structure Screen I [2% (v/v) 
PEG-400, 0.1 M HEPES (N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid) buffer, pH 7.5, 2.0 M ammonium 
sulfate] as the crystallization solution. The crystals diffracted to ~2.0 Å resolution and belonged to space group 
P212121, with unit-cell parameters a = 107.4, b = 131.6, c = 363.2 Å. With this large unit cell, the crystal contained 
eight copies of the 56 kDa '1-KSTD molecule per asymmetric unit. The enzyme’s structure determination, its 
structure description, site-directed mutagenesis experiments, and the conclusions on the enzyme’s catalytic 
mechanism have been reported6.  
3. Results 
3.1. The crystal structure of 3-ketosteroid-ǻ4-(5Į)-dehydrogenase from Rhodococcus jostii RHA1 
The crystal structure shows that '4-KSTD consists of two domains. One domain, called the F domain or FAD-
binding domain, contains a central five-stranded parallel E-sheet flanked on one side by four additional E-strands and 
on the other side by three D-helices. The FAD cofactor is bound non-covalently to this domain. The other domain is 
called the S domain or substrate-binding domain. It is a 134-residue insert into domain F and divides it into two 
parts, F1 (residues 7–291) and F2 (residues 426–489). The S domain consists of a four-stranded antiparallel E-sheet 
flanked on both sides by two D-helices. The domain organization and the three-dimensional structure of the domains 
resemble the fold of p-hydroxybenzoate hydroxylase7, a fold often observed in flavoenzymes8. The '4-KSTD 
structure is well defined, with the exception of residues 1–6, and the C-terminal residue 490. In addition, two loops 
near the active site (residues 170–182 and 256–268) are poorly visible in the electron density map, which may 
indicate flexibility. These loops may have a function in catalysis by shielding the FAD and substrate from the 
solvent. Fig. 2a gives an overview of the overall structure of the enzyme. 
3.2. The crystal structure of 3-ketosteroid-ǻ1-dehydrogenase from Rhodococcus erythropolis SQ1 
'1-KSTD crystallizes with eight monomers in the asymmetric unit. Although many hydrogen-bonding interactions 
exist between the protein molecules in the crystal, size exclusion chromatography indicated that the enzyme occurs 
as monomers in solution. Moreover, most residues involved in hydrogen bonding interactions in the dimer interface 
are relatively variable, and therefore we deem the intermolecular contacts observed in the '1-KSTD crystal structure 
as biologically not significant. The structure of '1-KSTD is very similar to that of '4-KSTD. Like '4-KSTD, the 
enzyme contains two domains, the F and S domains (Fig. 2b). The F domain contains the FAD cofactor and consists 
of two parts. The first part (residues 1-278) has a central five-stranded parallel E-sheet sandwiched by a three-D-helix 
bundle at one side and a twisted three-stranded E-meander and a D-helix at the other side. The second part (residues 
449–510) is mainly D-helical with two antiparallel E-strands. The substrate-binding domain comprises residues 279-
448, and is inserted into the F domain after residue 278 in E-strand 9. 
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Fig. 2. Ribbon drawing of the crystal structures of (a) '4-KSTD and (b) '1-KSTD. The catalytic domains (in pink) are at the top, and the FAD-
binding domains are at the bottom. In the FAD-binding domain, the first half, the second half, and the E-meander crossover of the EDEDE 
structural motif (subdomain F1) are coloured pale green, brown, and deep blue, respectively, whereas subdomain F2 is in deep teal. The side 
chains of the three catalytic residues in the active site, as well as the FAD, are shown in ball and stick representation with carbon atoms in blue.  
3.3. The binding of the FAD cofactor in '1-KSTD and '4-KSTD 
In both '1-KSTD and '4-KSTD the FAD molecule binds non-covalently in a long cleft in the F-domain. It adopts 
an extended conformation, with its adenosine 5ƍ-diphosphate part bound by a motif resembling the EDEDE 
dinucleotide binding motif frequently observed in flavoproteins9. The reactive isoalloxazine ring system is located 
close to the interface of F and S domains. Its si-face interacts with the FAD-binding domain, and its re-face faces the 
S domain. The O4, C4A, N5, and C5A atoms face the bulk solvent. In the case of '4-KSTD, the isoalloxazine ring 
system is not planar; the butterfly angle between the pyrimidine and dimethylbenzene rings is ~168°, similar to that 
observed in cholesterol oxidase10. In contrast, in '1-KSTD the isoalloxazine ring has an almost planar conformation. 
3.4. Product binding in 3-ketosteroid-ǻ4-(5Į)-dehydrogenase and 3-ketosteroid-ǻ1-dehydrogenase  
The 1.6 Å resolution structure of '4-KSTD with the bound product 4-androstene-3,17-dione (4-AD) shows that 4-
AD binds at the interface between the F and S domains, at the re-face of the isoalloxazine ring system, displacing 
three water molecules and the two acetate molecules that were present in the steroid-free enzyme structure (Fig. 3a). 
Binding of 4-AD does not cause significant changes in the overall protein structure; the all-atom RMSD between the 
structures is only 0.31 Å. The side chains of Trp136 and Ser320, which display a correlated double conformation in 
the steroid-free structure, become ordered upon binding of 4-AD. Trp136 has a hydrophobic stacking interaction with 
the steroid, but it is conserved in only a few putative '4-KSTDs11. A W136F substitution caused only a 3-fold 
reduction in apparent activity, but a W136A mutation resulted in inactive enzyme, indicating that an aromatic residue 
capable of stacking is required at this position4.  
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Fig. 3. Binding of the 3-ketosteroid product in the active site near the isoalloxazine ring system of the FAD co-factor. (a) Binding of 4-AD to '4-
KSTD; (b) Binding of ADD to '1-KSTD. In both figures the interaction distances (in Å) of the catalytic acid and the catalytic base, as well as the 
FAD N5 atom are indicated. In addition, in pink, the N-terminus of an active site D-helix is shown, of which the D-helix macro-dipole may 
stabilize the negative charge on the O3 and C2/C4 atoms. See text for further explanations.  
 
In '1-KSTD, the product (ADD) binds in a similar way in a pocket-like cavity that is lined with hydrophobic 
amino acid residues originating from both domains and bordered by the re-face of the isoalloxazine ring of FAD (Fig. 
3b). The apolar nature of the residues that line this pocket is conserved among '1-KSTD enzymes from different 
bacteria. The A-ring of the 3-ketosteroid is nearly planar and is buried in the active site pocket. It lies almost parallel 
to the plane of the isoalloxazine ring at the re-face of the pyrimidine moiety. It is sandwiched between the pyrimidine 
moiety of the isoalloxazine ring and residues Tyr119 and Tyr318. The five-membered D-ring of the 3-ketosteroid 
occupies a solvent-accessible pocket near the active site entrance.  
Comparing the product binding modes in '1-KSTD and '4-KSTD after superposing the 3D structures on the basis 
of their isoalloxazine rings revealed that ADD and 4-AD are bound in a similar orientation but rotated by ~40° in the 
plane of the steroid ring system (Fig. 4). Importantly, the C1, C2 and C3 carbonyl O atoms of ADD virtually 
superpose on the C5, C4 and C3 carbonyl O atoms of 4-AD, respectively (Fig. 4). The hydroxyl groups of Tyr487 
('1-KSTD) and Tyr466 ('4-KSTD) occupy a very similar position, making a hydrogen bond to the C3 carbonyl 
oxygen atom (see Fig. 3). The hydroxyl groups of Tyr318 ('1-KSTD) and Ser468 ('4-KSTD) have also a very 
similar position, and are at hydrogen-bonding distance to the C2/C4 carbon atom, respectively (Fig. 4). Finally, the 
N5 atom of the FAD isoalloxazine ring is in a position where it can accept a hydride ion from C1 ('1-KSTD) or C5 
('4-KSTD). Thus, the essential features of the catalytic residues of '1-KSTD and '4-KSTD are the same, and the 
positions of their reactive groups are very comparable. However, the steroid is bound in a different orientation, 
exposing either the C1-C2 bond ('1-KSTD) or the C4-C5 bond ('4-KSTD) to the catalytic residues. This different 
orientation fully explains the different regio-specificities of '1-KSTD and '4-KSTD. 
4. Discussion 
4.1. Catalytic mechanism of '1-KSTD and '4-KSTD  
4.1.1 A tyrosine residue is the catalytic acid 
In both '1-KSTD and '4-KSTD a conserved tyrosine has a hydrogen-bonding interaction with the C3 keto group 
of 4-AD/ADD. This suggests that this tyrosine (Tyr487 in '1-KSTD and Tyr466 in '4-KSTD) may function as the 
catalytic acid that protonates the C3 keto group, thereby promoting keto-enol tautomerization and labilization 
(acidification) of the hydrogen atoms at the neighbouring carbon atoms (C2, C4). Site-directed mutagenesis of this 
tyrosine in '4-KSTD (Y466A and Y466F) resulted in catalytically dead '4-KSTD enzymes4, confirming the 
importance of Tyr466 and showing that the hydroxyl group is critical for the reaction. In contrast, the equivalent 
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Tyr487F mutation in '1-KSTD had a relatively modest effect with a residual activity of ~2.6% of that of the wild-
type enzyme, despite the hydrogen bonding interaction of the hydroxyl group of Tyr487 with the C3 carbonyl 
oxygen of ADD6. An explanation for this observation could be that the backbone amide of Gly491 also makes a 
hydrogen bond with the C3 carbonyl oxygen that might partly compensate for the loss of the Tyr487 hydrogen-
bonding interaction6.  
 
 
4.1.2 A hydroxyl group of a serine or tyrosine residue abstracts the proton from the D-carbon atom  
In '4-KSTD, the Ser468 hydroxyl group is at 3.1 Å from the C4 atom of 4-AD, a position compatible with a role 
as the catalytic base that abstracts a proton from C4. Similarly, in '1-KSTD the hydroxyl group of Tyr318 is in a 
position to abstract a proton from C2. Site-directed mutagenesis of Ser468 (Ser468Ala) and Tyr318 (Tyr318Phe) 
abolished all catalytic activity, confirming that these residues are absolutely essential for catalytic activity4,6. Both the 
Ser468-OH and the Tyr318-OH are part of an extensive hydrogen-bonding network that can effectively relay the 
abstracted proton to the solvent. In '4-KSTD, proton transfer can take place via the Tyr319 hydroxyl group, a water 
molecule, and the side chain of Glu290. In '1-KSTD, the proton can be relayed via the Tyr119 hydroxyl group. 
Proton relay is indeed essential for catalysis, since a Tyr319Phe ('4-KSTD) and Tyr119Phe ('1-KSTD) mutation 
gave a drastic reduction of the enzyme’s activity, with only 0.0 - ~0.05% of the wild-type specific activity 
remaining4,6. 
4.1.3 The N5 atom of the FAD cofactor is well positioned to abstract a hydride ion from the substrate 
In '4-KSTD the N5 nitrogen in the isoalloxazine ring system is at a distance of 3.9 Å from the C5 atom of the 
product, and the N10-N5-C5 angle is ~108°. Such a distance and angle have also been found in other proteins12, and 
suggest that the FAD N5 atom is in a productive position for attack of the C5 atom of the substrate. The FAD N5 
atom is situated above the steroid, and the catalytic base Ser468 is below the 4-AD, which is in agreement with trans-
dehydrogenation of the substrate13. A similar situation exists in '1-KSTD, where the FAD N5 atom is in a productive 
position near the ADD’s C1 atom above the plane of the steroid A ring, and the Tyr318 hydroxyl group is below the 
plane. Thus, the N5 atom of FAD has the correct position to accept a hydride ion from the C5 atom (in '4-KSTD) or 
the C1 atom (in '1-KSTD). 
4.1.4 The catalytic mechanism 
The catalytic cycle of a typical flavoenzyme comprises two half-reactions, i.e., a reductive half-reaction and an 
oxidative half-reaction14. In the reductive half-reaction, the flavin coenzyme is reduced by a substrate, whereas in the 
oxidative half-reaction, the reduced coenzyme is reoxidized by an electron acceptor14. Based on our structural and 
mutational studies described above, a detailed catalytic mechanism of the reductive half-reaction can now be 
proposed (Fig. 5). The oxidation of 5D-AD or 1-(5D)-AD (Fig. 1) requires the abstraction of two hydrogen atoms and 
the transfer of two electrons as a hydride ion to the FAD. It is not known whether these proton and hydride transfers 
occur in a concerted or stepwise manner. Catalysis is likely initiated by protonation of the 3-keto-group by the 
catalytic acid. This acidifies/labilizes the C2 and C4 hydrogen atoms because of keto-enol tautomerization. Next, or 
concomitantly, the catalytic base abstracts a proton from the C2 or C4 atom, and relays the abstracted proton to the 
Fig. 4. Comparison of the binding of 4-androstene-3,17-dione (4-AD; 
blue) to '4-KSTD and 1,4-androstadiene-3,17-dione (ADD; green) 
bound to '1-KSTD. The ketosteroid structures were aligned based on 
superposition of the isoalloxazine ring system of the two enzymes. An 
angle of approximately 40 degrees is observed between the bound ADD 
and 4-AD products. The cross-structure distances between Ser468 in 
'4-KSTD and the site of attack on 4-AD, and between Tyr318 in '1-
KSTD and the site of attack on ADD, respectively, are indicated. 
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solvent as discussed above. A transient carbanionic species is formed, which is most likely stabilized by keto-enol 
tautomerization. The negative charge of this species is then transferred to the C1 or C5 atom to form the C1-C2 or 
C4-C5 double bond. In concert with this, the axial D-hydrogen, which is in close proximity to the re-face of the N5 
of the isoalloxazine ring, is transferred as a hydride ion to the N5 atom, generating a semi-reduced anionic FAD. The 
negative charge of this anion is likely delocalized over the pyrimidine moiety of the isoalloxazine ring system. A 
nearby active site D-helix may help stabilizing the negative charge by its N-terminal macro-dipole (Fig. 3). 
Reoxidation of the FAD in the subsequent oxidative half-reaction will make the enzyme ready for another cycle of 
catalysis.  
 
 
Fig. 5. Proposed reaction mechanism of '1- and '4-3-ketosteroid 
dehydrogenases, as exemplified by the formation of a C4-C5 
double bond4. Panel 1, catalysis is initiated by the interaction of 
the O3 keto group of the substrate with the hydroxyl group of 
the catalytic acid (Tyr487/Tyr466), which promotes keto-enol 
tautomerization and labilization of the C2 and C4 hydrogen 
atoms. The catalytic base (Tyr318/Ser468) abstracts a proton 
from the C2/C4 atom of the substrate, with a tyrosine 
(Tyr119/Tyr319) serving as a proton relay system to the solvent. 
Panel 2, next, the FAD abstracts a hydride ion from the C1 or 
C5 carbon of the substrate, which, with a concomitant 
rearrangement, results in the formation of a double bond 
between C1-C2 or C4-C5. Panel 3, the product is formed and 
leaves the active site. The negative charge on the reduced FAD 
is stabilized by the dipole moment of a nearby D-helix. 
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5. Conclusions 
3-Ketosteroid dehydrogenases are flavoproteins that play key roles in steroid ring degradation. Elucidation of 
crystal structures of two such enzymes, the 3-ketosteroid-'1-dehydrogenase from Rhodococcus erythropolis SQ1 and 
the 3-ketosteroid-ǻ4-(5Į)-dehydrogenase from Rhodococcus jostii RHA1, has revealed for the first time their three-
dimensional structures. The two enzymes have a very similar fold, which contains two domains that are similar to the 
fold of other FAD-containing proteins. Crystal structures with bound products allowed establishing the catalytic 
residues, and a catalytic mechanism could be proposed. Intriguingly, the two enzymes have only one catalytic residue 
in common, a tyrosine that binds the 3-keto-group of the steroid substrate. The other two catalytic residues come 
from very different parts of the protein, and therefore it is an interesting question how in the course of evolution the 
'1- and '4-KSTDs have diverged. Because there are many more '1-KSTDs than '4-KSTDs found in nature, it is 
likely that '4-KSTDs are a more recent addition to the 3-ketosteroid dehydrogenase repertoire. Since both enzymes 
use the FAD cofactor for abstracting a hydride ion from the substrate, it seems likely that positioning the substrate’s 
C5 atom instead of the C1 atom near the reactive N5 atom of the FAD should have been a crucial step in their 
divergence. As shown by the crystal structures of the'1- and '4-KSTD enzymes, the change in binding position of 
the substrate is achieved via a rotation, whereby the substrate’s C3 carbonyl group retains its position, and also the 
catalytic acid keeps its function. Although in both KSTDs the steroid A- and B-rings fit tightly in a hydrophobic 
pocket, a certain degree of flexibility must have been possible in the last common ancestor to allow such a rotation. 
As shown in Fig. 4, the two catalytic base residues (Tyr318 in '1-KSTD and Ser468 in '4-KSTD) are both at a 
good distance (3.2-3.6 Å) from the steroid’s carbon atom that is to be deprotonated, in both the '1- and '4- 
orientations of the substrates. In other words, Tyr318 in'1-KSTD may be able to deprotonate the substrate in both 
the'1- and'4-KSTD substrate orientations. Similarly, Ser468 in'4-KSTD would also have a position suitable for 
deprotonating the substrate in both orientations. Thus, from these observations we conclude that the necessity of a 
drastic change in the catalytic base and associated proton transfer residue is not obvious. Therefore, it seems possible 
that other enzymes with '4-KSTD activity exist that use the'1-KSTD catalytic tyrosine residues, but that so far have 
escaped identification by bioinformatics methods. 
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